Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs

NEXT STORY
Dynavax Donates 10,000 Doses of HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted] Vaccine to Emergency Healthcare Providers and Hospital Staff to Protect Against Hepatitis B Infections Amidst COVID-19 Pandemic
PREV STORY
Recordati Rare Diseases now holds Isturisa® European MA
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cynata Reports Positive 28-day Data From Cohort B of Phase 1 Trial of CYP-001 in GvHD

MELBOURNE, Australia, June 21, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine ...

author_avatar
NASDAQ Market News

NeRRe Therapeutics raises £20 million in a Series B2 financing round

author_avatar
NASDAQ Market News

Roche’s Xofluza approved by the European Commission for the treatment of influenza, the first new influenza antiviral for patients in almost 20 years

author_avatar
NASDAQ Market News